Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals.
Effects of carbenoxolone Na on acute or chronic types of gastric lesions or ulcer models produced in rats, guinea pigs, or dogs were studied. Carbenoxolone Na, given either orally or intraperitoneally, produced a significant inhibition of stress-induced gastric lesions in intact or in pylorus-ligated rats. Acetylsalicylic acid (ASA)-induced or serotonin-induced gastric lesions in rats were also inhibited significantly by pretreatment with the drug. However, carbenoxolone Na did not affect the development of Shay ulceration in rats even though the peptic activity in gastric juices was markedly reduced by the drug. Histamine-induced gastric lesions in guinea pigs were not prevented by pretreatment with carbenoxolone Na. Although carbenoxolone Na, given for 10-20 days, did not promote the healing of stress-induced gastric lesions and acetic acid gastric jlcers in rats, it significantly accelerated the healing of chronic gastric ulcer produced in dogs by 3 weeks' treatment. Carbenoxolone Na prevented the acid back-diffusion caused by ASA without any influence on Na+ efflux in pylorus-ligated rats.
D000208:Acute Disease; D000818:Animals; D001241:Aspirin; D002229:Carbenoxolone / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D004195:Disease Models, Animal; D004285:Dogs; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D006168:Guinea Pigs; D006632:Histamine; D006801:Humans; D008026:Ligation; D008297:Male; D011708:Pylorus / Q000601:surgery; D051381:Rats; D012701:Serotonin; D013276:Stomach Ulcer / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D013315:Stress, Psychological; D014315:Triterpenes / Q000627:therapeutic use*
D014315:Triterpenes; D012701:Serotonin; D006632:Histamine; D002229:Carbenoxolone; D001241:Aspirin